EHN is involved in several ongoing EU-funded research projects as a patient representative partner in each consortium. EHN’s primary role is to bring the patient perspective to the design and development of each project and to facilitate active and structured patient engagement in each project.
AIDAVA is a four-year project mainly funded by the Horizon Europe programme coordinated by the Universiteit Maastricht.
HYPERMARKER is a four-year international research project that received a 10 million euro grant from Horizon Europe and UK Research and Innovation.
AI4HF is a 4-year Horizon Europe project that aims to co-design, develop, evaluate and exploit an integrative and trustworthy artificial intelligence (AI) solution for personalised heart failure (HF) risk assessment.
More information coming soon.